Results 181 to 190 of about 42,159 (230)
Some of the next articles are maybe not open access.

Varicella zoster virus

Journal of the American Academy of Dermatology, 1999
Because of its ability to produce two clinically distinct disease entities (chickenpox and shingles), varicella zoster virus (VZV) is an unusual etiologic agent. Although in the past viral exanthems were mostly only of academic interest to the practitioner, the development of antiviral agents and the newly approved varicella (OKA) vaccine have ...
M L, McCrary, J, Severson, S K, Tyring
openaire   +4 more sources

Varicella-zoster Virus

Nihon rinsho. Japanese journal of clinical medicine, 2010
Varicella Zoster virus (VZV) is an alpha herpesvirus that causes chicken pox (varicella), usually in childhood. Following primary infection, VZV establishes a latent infection in the sensory nerve ganglia. Reactivation of VZV from the dorsal root ganglia, known as shingles or herpes zoster, may be seen decades later, usually in older people and ...
Toshiharu, Yamashita   +3 more
  +5 more sources

Varicella Zoster Virus

Pediatrics In Review, 2019
1. Robyn J. Blair, MD 1. Department of Pediatrics, Stony Brook University School of Medicine, Stony Brook, NY Varicella zoster virus (VZV), human herpesvirus 3, is a highly contagious virus found worldwide. Humans are the only known reservoir. Transmission is via respiratory droplets, aerosolized vesicular contents, or direct contact with skin ...
openaire   +2 more sources

Varicella zoster virus–associated polyradiculoneuritis

Neurology, 2009
We describe a case of polyradiculoneuritis in an elderly patient with pleocytosis, raised proteins in CSF, and varicella zoster virus (VZV) DNA in the CSF without cutaneous rash. ### Case description. A 79-year-old man presented in September 2008 with subacute onset of lower limb flaccid paralysis, the day after an episode of diarrhea with ...
A. Cortese   +7 more
openaire   +3 more sources

Varicella-Zoster Virus Infection

Annals of Internal Medicine, 1988
Excerpt To the editor: The conference on varicella zoster by Strauss and colleagues (1) may indeed reflect one viewpoint on using medications for treating zoster, but it certainly does not reflect ...
openaire   +2 more sources

Varicella-Zoster Virus Vaccine

JAMA: The Journal of the American Medical Association, 1977
THE RECENT REPORTS of Takahashi and his associates1-6in Japan on the effectiveness and innocuity of a live, attenuated varicella-zoster virus vaccine call for an examination of the nature and magnitude of the disease problem to be prevented and of the other factors on which a decision to use such a vaccine must be based.
openaire   +2 more sources

Varicella-Zoster Virus

Archives of Otolaryngology - Head and Neck Surgery, 1972
The complement fixing (C-F) antibody titers to varicella-zoster and herpes simplex virus in 80 cases of peripheral facial nerve paralysis were determined in association with the inflammatory findings in the increased antibody group. Of 22 patients with Ramsay-Hunt's syndrome, 18 (81%) showed more than eightfold increases in complement fixing antibody ...
H. Tomita, W. Hayakawa
openaire   +1 more source

Varicella Zoster Virus

Pediatric Infectious Disease Journal, 2013
Varicella zoster virus (VZV) generally causes self-limiting, two distinct clinical diseases with predominantly cutaneous manifestations and little mortality and morbidity. However, VZV could also cause pneumonitis with potentially lethal effects in otherwise healthy adults and immunocompromised individuals. In fact, this complication is regarded as one
Ali Akalin   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy